Tags

Type your tag names separated by a space and hit enter

Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Can Respir J. 2000 Jul-Aug; 7(4):313-9.CR

Abstract

BACKGROUND

A direct comparison of the protective effects of single and regular doses of inhaled glucocorticoid on allergen-induced asthmatic responses and inflammation has not been made.

OBJECTIVE

To compare the effects of pretreatment with fluticasone 250 microg 30 min before allergen inhalation and two weeks of 250 microg twice daily (last dose 24 h before challenge) with single and regular (twice daily) placebo doses on early and late asthmatic responses, induced sputum cell counts and measures of eosinophil activation at 7 h and 24 h, and methacholine airway responsiveness at 24 h.

PATIENTS AND METHODS

Ten mild asthmatic patients were studied in a randomized, double-blind, placebo controlled crossover study.

RESULTS

Regular fluticasone increased the baseline mean provocative concentration of methacholine to cause a 20% fall (PC20) in forced expiratory volume in 1 s (FEV1) from 2.6 to 6.4 mg/mL (P<0.05) and lowered the eosinophil count from 3.1% to 0.4% (P<0.05) compared with regular placebo. Neither single nor regular fluticasone had any effect on the early asthmatic response. Single fluticasone attenuated the late asthmatic response, the mean +/- SEM maximum percentage fall in FEV1 (10.8+/-3.6 compared with single placebo 18. 8+/-3.5, P=0.03), the allergen-induced increase of airway responsiveness (P<0.05), and the eosinophilia (P<0.005) and activated eosinophils at 7 h (P<0.01) but not at 24 h. Regular fluticasone also attenuated the late asthmatic response (11.1+/-2.5) compared with regular placebo (19.6+/-4.5), but this was not statistically significant and did not protect against the induced increase in airway responsiveness or the sputum eosinophilia.

CONCLUSION

Two weeks of regular inhaled fluticasone discontinued 24 h before allergen challenge does not offer any additional protection against the early or late asthmatic responses, increased airway responsiveness or sputum eosinophilia compared with a single dose of 250 microg immediately before allergen challenge, despite increasing baseline PC20 and decreasing sputum eosinophilia prechallenge. The significance of the protective effect of a single dose of inhaled steroid before an allergen inhalation and the duration of the protective effect need further investigation.

Authors+Show Affiliations

Department of Medicine, St Joseph's Hospital, Hamilton, Ontario, Canada.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

10980457

Citation

Parameswaran, K, et al. "Protective Effects of Fluticasone On Allergen-induced Airway Responses and Sputum Inflammatory Markers." Canadian Respiratory Journal, vol. 7, no. 4, 2000, pp. 313-9.
Parameswaran K, Inman MD, Watson RM, et al. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers. Can Respir J. 2000;7(4):313-9.
Parameswaran, K., Inman, M. D., Watson, R. M., Morris, M. M., Efthimiadis, A., Ventresca, P. G., Lam, R., O'Byrne, P. M., & Hargreave, F. E. (2000). Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers. Canadian Respiratory Journal, 7(4), 313-9.
Parameswaran K, et al. Protective Effects of Fluticasone On Allergen-induced Airway Responses and Sputum Inflammatory Markers. Can Respir J. 2000 Jul-Aug;7(4):313-9. PubMed PMID: 10980457.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers. AU - Parameswaran,K, AU - Inman,M D, AU - Watson,R M, AU - Morris,M M, AU - Efthimiadis,A, AU - Ventresca,P G, AU - Lam,R, AU - O'Byrne,P M, AU - Hargreave,F E, PY - 2000/9/12/pubmed PY - 2001/2/28/medline PY - 2000/9/12/entrez SP - 313 EP - 9 JF - Canadian respiratory journal JO - Can. Respir. J. VL - 7 IS - 4 N2 - BACKGROUND: A direct comparison of the protective effects of single and regular doses of inhaled glucocorticoid on allergen-induced asthmatic responses and inflammation has not been made. OBJECTIVE: To compare the effects of pretreatment with fluticasone 250 microg 30 min before allergen inhalation and two weeks of 250 microg twice daily (last dose 24 h before challenge) with single and regular (twice daily) placebo doses on early and late asthmatic responses, induced sputum cell counts and measures of eosinophil activation at 7 h and 24 h, and methacholine airway responsiveness at 24 h. PATIENTS AND METHODS: Ten mild asthmatic patients were studied in a randomized, double-blind, placebo controlled crossover study. RESULTS: Regular fluticasone increased the baseline mean provocative concentration of methacholine to cause a 20% fall (PC20) in forced expiratory volume in 1 s (FEV1) from 2.6 to 6.4 mg/mL (P<0.05) and lowered the eosinophil count from 3.1% to 0.4% (P<0.05) compared with regular placebo. Neither single nor regular fluticasone had any effect on the early asthmatic response. Single fluticasone attenuated the late asthmatic response, the mean +/- SEM maximum percentage fall in FEV1 (10.8+/-3.6 compared with single placebo 18. 8+/-3.5, P=0.03), the allergen-induced increase of airway responsiveness (P<0.05), and the eosinophilia (P<0.005) and activated eosinophils at 7 h (P<0.01) but not at 24 h. Regular fluticasone also attenuated the late asthmatic response (11.1+/-2.5) compared with regular placebo (19.6+/-4.5), but this was not statistically significant and did not protect against the induced increase in airway responsiveness or the sputum eosinophilia. CONCLUSION: Two weeks of regular inhaled fluticasone discontinued 24 h before allergen challenge does not offer any additional protection against the early or late asthmatic responses, increased airway responsiveness or sputum eosinophilia compared with a single dose of 250 microg immediately before allergen challenge, despite increasing baseline PC20 and decreasing sputum eosinophilia prechallenge. The significance of the protective effect of a single dose of inhaled steroid before an allergen inhalation and the duration of the protective effect need further investigation. SN - 1198-2241 UR - https://www.unboundmedicine.com/medline/citation/10980457/Protective_effects_of_fluticasone_on_allergen_induced_airway_responses_and_sputum_inflammatory_markers_ L2 - https://dx.doi.org/10.1155/2000/254213 DB - PRIME DP - Unbound Medicine ER -